Luciana KASE TANNO
  • E-mail :[email]
  • Phone : +33684437939
  • Location : Montpellier, France
Last update 2025-02-21 10:21:43.97

Luciana KASE TANNO MD, PhD, HDR Allergy and Clinical Immunology

Course and current status

Dr Luciana Kase Tanno, MD PhD

Director of the WHO Montpellier Collaborating Centre on Classification Scientific Support, allergist and clinical immunologist, and researcher at the University Hospital of Montpellier and the Desbrest Institute of Epidemiology and Public Health, Montpellier, France.

Board member of the Medical Scienttific Advisory Committee (MSAC) of the WHO for the international classifications.

Member of the Board of directors of the World Allergy Organization (WAO), chair of the WAO Centers of Excellence committee, liaison of the WAO anaphylaxis committee and senior advisor of the WAO Junior Members.

Board member of the French Allergy Society (SFA) and co-chair of the SFA anaphylaxis committee.

Editor-in-chief of the Journal of Allergy & Hypersensitivity Diseases (JAHD).

PERSONAL INFORMATION

Family name, First name: KASE TANNO, Luciana; ORCID: 0000-0003-3236-1225, Nationality: Brazilian

EDUCATION

MD (2001), Certified Allergist and clinical immunologist (2006), PhD (2014): University of Sao Paolo, Brazil

Post-doctoral fellow: 2015-2016, University Hospital of Montpellier, France; 2016-2020, Team Epidemiology of Allergic and Respiratory Diseases Institut Pierre Louis d’Epidémiologie et de Santé Publique UMRS 1136; 2021-current, Institute Desbrest of Epidemiology and Public Health (IDESP), UA-11, INSERM University of Montpellier

Habilitation to conduct research (HDR) in Medicine: 2018, University of Montpellier, France

CURRENT POSITIONS (no career breaks)

Researcher (University Hospital of Montpellier and Institute Desbrest of Epidemiology and Public Health, UA-11, INSERM University of Montpellier). Lecturer in Health Science (Epidemiology and Public Health) (since 2014, Postgraduate Program in Health Sciences, IAMSPE, São Paulo, Brazil), Board member of the Medical and scientific advisory committee of the WHO (since 2017), Board of Directors member of the World Allergy Organization (WAO) (since 2017), Co-director of the WHO Collaborating Center for Classification Scientific Support, University Hospital of Montpellier, France; ExCom member of the French Allergy Society (SFA) (since 2021), Co-Chair of the Anaphylaxis Special Committee of the WAO and of the SFA (since 2020). Institutional responsibility: Director of the Montpellier WHO Collaborating Centre, University Hospital of Montpellier, France (since 2018)

PREVIOUS POSITIONS

Post-doctoral fellow (2015- 2021, University Hospital of Montpellier, France); Hospital practitioner (2006-2015) at: Department of Allergy and Clinical Immunology, University of Sao Paulo, Nipo-brasileiro Hospital, Hospital Sirio-Libanes, Sao Paulo, Brazil; Allergist at private office (2006-2015)– Allergy and Clinical Immunology, Sao Paulo, Brazil, Medical assistant (2009-2015), Department of Allergy and Clinical Immunology of Servidor Publico Estadual de Sao Paulo Hospital, Sao Paulo, Brazil; Founding member (2011) and chair (2014-2015) of the WAO Junior Members Group; Board member of the Drug Allergy Special Committee of the World Allergy Organization (2012-2013), Chair (2015-2016) and Senior Advisor (2016-2019) of the Latin-American Society of Asthma Allergy and Immunology (SLAAI) Junior Members Group; Chair of the Scientific Committee of the Centers of Excellence of WAO (2018-2019)

FELLOWSHIPS AND AWARDS

2009 and 2010: Lain Pontes Prize of the Brazilian Association of Allergy and Immunology (ASBAI); 2011: Research Fellowship in pharmacogenetics, University of Liverpool, UK; 2012: Clinical Fellowship – Recipient of a European Academy of Allergy and Clinical Immunology (EAACI) grant, University Hospital of Montpellier, France; 2011-2023: 4 travel grants from EAACI and 1 from WAO, 3 best posters prizes from the EAACI; 2015-2016: Research Post-doctoral Fellow - Recipient of CNPq grant – Brazilian National, Council for Scientific and Technological Development, Science without borders, University Hospital of Montpellier, France; 2019 – current: 5 travel grants/ best posters prizes from WAO for supervised students; 2024: Recipient of Science Award for Allergy Innovation – mid-career category of the Stallergenes Greer Foundation and International Member of Honor of the Argentinian Association of Allergy Asthma and Clinical Immunology (AAAeIC)

ORGANISATION OF SCIENTIFIC MEETINGS (as scientific committee member)

2011: II International Symposium on Anaphylaxis, Urticaria and Drug Allergy, Sao Paulo, Brazil; 2014: WAO International Scientific Conference, Rio de Janeiro, Brazil; 2015: World Allergy Organization Congress, Seoul, Korea; 2016: WAO International Scientific Conference, Jerusalem, Israel; 2018: AAAAI/WAO Joint Congress, Orlando, USA, WAO International Scientific Conference, Florence, Italy, French Allergy Congress, Paris, France (annually); 2019: WAO International Scientific Conference, Beirut, Lebanon, World Allergy Organization Congress, scientific committee, Lyon, France; 2021: World Allergy Week on Anaphylaxis

MAJOR COLLABORATIONS

Member of the International Consortium on Drug Hypersensitivity (Welcome Trust-University & Liverpool University); Member of the Consortium of Allergy Academies ICD-11; Member of the WHO-FIC (Family of International Classifications) network

GRANTS (co-coordination)

2011-2014: FAPESP, research public found (RPF), Brazil (148KUSD); 2015-2016: CNPq, RPF, Brazil (321K€); 2016-2018: unrestricted grant (UG), AstraZeneca (72K€), 2017-2019: UG, Mylan (72K€); 2017-2020: UG, Novartis (75 K€); 2018: GIRCI SOHO (APITHEM), RPF (49 946 €); 2019-2021: AllerGOS, research grant (20 K€), 2020-2023: Agence du Numérique en Santé (ANS), RPF (300 K€), 2024-2028 : NEXUS, Universite de Montpellier (60k)

SUPERVISION OF GRADUATE STUDENTS AND POSTDOCTORAL FELLOWS

2010-2014             10 medical residents (Academic Allergy Specialization Projects), Sao Paulo, Brazil

2014 – current        2 master students per year, Postgraduate Program in Health Sciences, IAMSPE, São Paulo, Brazil

2018 – current        2 medical residents per year (Academic Allergy Specialization Projects), University of Montpellier, France

2021 – current        2 master students per year (M1 and M2), University of Montpellier, France

2018 – current        1 PhD student per year and 2 co-directions with collaborative projects, University of Montpellier, France

TEACHING ACTIVITIES

2011 – current         Academic teaching activities for WAO Junior Members (symposium and practical courses during biannual WAO meetings) 

2017 – current         Allergy lectures (22 hrs), University Hospital of Montpellier, France

2021 – current         Master degree of “epidemiology, health data and biostatistics” (20 hrs), University of Montpellier

Scientific summary

PUBLICATIONS

163 publications (18 in IF>10 journals); Global SIGAPS: 1677 and; Indice H: 37, 6395 citations (Feb 2025). Original articles: 53 (24 as first or co-first, 6 as last, 5 as co-last author, 29 as corresponding author) . Reviews, systematic reviews, position papers, guidelines: 110 (38 as first or co- first, 6 as last, 2 as co-last author, 44 as corresponding author)

REVIEWING ACTIVITIES

Frequent reviewer of: Respiratory Care (≥ 2009, IF:2.0), Allergy (≥ 2015, IF:8.7), Pediatric Allergy and Immunology (≥ 2015, IF: 4.1), PlosOne (≥ 2015, IF: 2.7), Asian Pacific Journal of Allergy and Immunology (≥ 2015, IF: 1.0), Journal of Medical Internet Research (≥ 2016, IF: 4.6), WAO Journal (≥ 2015, IF: 3.5), European Journal Allergy & Immunology (≥ 2017, IF: 4.1), Clinical and Translational Allergy (≥ 2018, IF: 5.1), BMJ British Medical Journal (≥ 2018, IF: 20.7), Annals of Allergy, Asthma and Immunology (≥ 2018, IF: 3.5), BMC Medical Research (≥ 2019, IF: 2.5), Journal of Healthcare Engineering (≥ 2019, IF: 1.3), Clinical Experimental Allergy (≥ 2020, IF: 4.7), Bulletin of the World Health Organization (≥ 2020, IF: 6.9), British Journal of Anesthesia (≥2023, IF: 9.8) . Editorial Board of WAO Journal (≥ 2015, IF: 5.5); Vaccines (≥2020, IF: 4.9), Frontiers of Allergy (≥2020), Current Opinion of Allergy & Clinical Immunology (≥2022, IF: 3.2). Editor-in-chief of the Journal of Allergy & Hypersensitivity Diseases (≥2022).

Image d’exemple